|
Dabur India Ltd drops for fifth straight session> |
|
Dabur expects double-digit Q1 revenue, PAT growth on resilient domestic demand> |
|
Dabur India declare Quarterly Result> |
|
Dabur India Ltd down for fifth straight session> |
|
Dabur India says US FDA issues import alert for Silvassa plant drugs> |
|
Dabur India allots 2.62 lakh equity shares under ESOS> |
|
Dabur India jumps Q4 PAT climbs 15% YoY to Rs 369 cr> |
|
Dabur India Ltd spurts 3.73%, gains for five straight sessions> |
|
Dabur India AGM scheduled> |
|
Board of Dabur India recommends final dividend> |